Significant Surge in HK Pharma Stocks Led by CSPC Pharma and Others
Hong Kong pharmaceutical stocks experienced a notable rally with CSPC Pharma leading the surge, rising over 13%. Other major gainers included Lepu Bio up 7%, Hengrui Pharma and Junshi Bio up 6%, and HBM, Beigene, and Sihuan Pharma each up around 5%. This broad rally in the innovative drug sector reflects strong market momentum and investor interest in these companies.